METHODS FOR TREATING LEUKEMIA AND USE OF A LEUKEMIC STEM CELL SIGNATURE TO PREDICT CLINICAL SENSITIVITY TO THERAPIES

Provided herein are methods of using certain biomarkers, such as gene sets (e.g., a leukemic stem cell (LSC) signature), in predicting and monitoring clinical sensitivity and therapeutic response to certain compounds in patients having various diseases and disorders, such as cancer (e.g, lymphoma, m...

Full description

Saved in:
Bibliographic Details
Main Authors LOOS, Remco Gerard, POURDEHNAD, Michael, MACBETH, Kyle James, FAN, Jinhong, PIERCE, Daniel Weston
Format Patent
LanguageEnglish
French
German
Published 07.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided herein are methods of using certain biomarkers, such as gene sets (e.g., a leukemic stem cell (LSC) signature), in predicting and monitoring clinical sensitivity and therapeutic response to certain compounds in patients having various diseases and disorders, such as cancer (e.g, lymphoma, multiple myeloma (MM), and leukemia, such as acute myeloid leukemia (AML)). Also provided herein are methods of treating diseases using the treatment compounds.
AbstractList Provided herein are methods of using certain biomarkers, such as gene sets (e.g., a leukemic stem cell (LSC) signature), in predicting and monitoring clinical sensitivity and therapeutic response to certain compounds in patients having various diseases and disorders, such as cancer (e.g, lymphoma, multiple myeloma (MM), and leukemia, such as acute myeloid leukemia (AML)). Also provided herein are methods of treating diseases using the treatment compounds.
Author LOOS, Remco Gerard
PIERCE, Daniel Weston
POURDEHNAD, Michael
MACBETH, Kyle James
FAN, Jinhong
Author_xml – fullname: LOOS, Remco Gerard
– fullname: POURDEHNAD, Michael
– fullname: MACBETH, Kyle James
– fullname: FAN, Jinhong
– fullname: PIERCE, Daniel Weston
BookMark eNqNissKwjAQAHPQg69_2B8QfNLzkm7bxTQpyVbwVIrEk7SF9v9RQe-eBmZmqWZd38WFmkqSwqUBMudBPKGwzcFQfaGSEdCmUAcClwH-rIYgVIImYyBwblFqTyAOKk8pawFt2LLGdyUbWPjKcvt0KchjxRTWav5on2PcfLlSkJHoYhuHvonj0N5jF6eGqtPuvD8kCe6Pfywvgc46Cw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
DocumentTitleAlternate VERFAHREN ZUR BEHANDLUNG VON LEUKÄMIE UND VERWENDUNG EINER LEUKÄMIE-STAMMZELLSIGNATUR ZUR VORHERSAGE DER KLINISCHEN EMPFINDLICHKEIT AUF THERAPIEN
MÉTHODES DE TRAITEMENT DE LA LEUCÉMIE ET UTILISATION D'UNE SIGNATURE DE CELLULES SOUCHES LEUCÉMIQUES POUR PRÉDIRE LA SENSIBILITÉ CLINIQUE À DES THÉRAPIES
ExternalDocumentID EP4051277A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP4051277A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:26:31 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP4051277A13
Notes Application Number: EP20200883274
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220907&DB=EPODOC&CC=EP&NR=4051277A1
ParticipantIDs epo_espacenet_EP4051277A1
PublicationCentury 2000
PublicationDate 20220907
PublicationDateYYYYMMDD 2022-09-07
PublicationDate_xml – month: 09
  year: 2022
  text: 20220907
  day: 07
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies Celgene Corporation
RelatedCompanies_xml – name: Celgene Corporation
Score 3.4189153
Snippet Provided herein are methods of using certain biomarkers, such as gene sets (e.g., a leukemic stem cell (LSC) signature), in predicting and monitoring clinical...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Title METHODS FOR TREATING LEUKEMIA AND USE OF A LEUKEMIC STEM CELL SIGNATURE TO PREDICT CLINICAL SENSITIVITY TO THERAPIES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220907&DB=EPODOC&locale=&CC=EP&NR=4051277A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG8Ift4UNeJXejC7LeLGVnYgZnQdm-4rrBA8ETq3hMsgMuO_71sF9KK35jV5ad_Lr-2vfe8VoXvSIUVGhK7qRVETFIOolmYaaqYX87xnZUSTng4j0xt3n6fGtIEW21wYWSf0UxZHBERlgPdKrtern0ssR8ZWrh_EAkTLJ5f3HWXDjjWtA2RPcQZ9lsROTBVKoaVEoz6M4lEjxAaitAenaFKDgU0GdVLK6veO4p6g_QSUldUpauRlCx3R7cdrLXQYbt67W-hABmhmaxBuQLg-Q1XIuBc7KQYCh_mI2dyPhjhg4xewqY3tyMHjlOHYxfZWSnHKWYgpCwKc-sPvYAfMYwwOcHzKMQ38qK6MgFMWpT73Jz5_rfu5x0Z2AkfGc4RdxqmnwkRmO6PNWLKbsn6BmuWyzC8R1nR9bhqiZxFBukK35pbomqZVCB08Q8hbG7X_VHP1T981Oq6tL4OvyA1qVu8f-S3s1pW4k3b-Ai6Ojz8
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG-IX3hT1IifPZjdFnFlKzsQM7qOTfZBWCF4ImxuCZdBZMZ_37cK6EVvzWvy0r6X1_bX_t4rQg-0RfOUJkQleV4BFJ2qpmboakryedYxU6pJTweh4Y7bL1N9WkOLbS6MrBP6KYsjQkSlEO-lXK9XP5dYtuRWrh-TBYiWz47o2soGHWtaC8CeYve6fBjZEVMYg5YSjrowiieNUguA0j6csGkVDHzSq5JSVr93FOcEHQxBWVGeolpWNFCdbT9ea6CjYPPe3UCHkqCZrkG4CcL1GSoDLtzIjjEAOCxG3BJe2Mc-Hw_Apha2QhuPY44jB1tbKcOx4AFm3Pdx7PW_yQ5YRBgcYHtMYOZ7YVUZAcc8jD3hTTzxWvULl4-sIRwZzxF2uGCuChOZ7Yw248PdlMkF2iuWRXaJsEbI3NCTjkkT2k6IOTeTtmGYeULAM5S-NVHzTzVX__Tdo7orAn8Ggx1co-PKE5KIRW_QXvn-kd3Czl0md9LmXxPZkjI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=METHODS+FOR+TREATING+LEUKEMIA+AND+USE+OF+A+LEUKEMIC+STEM+CELL+SIGNATURE+TO+PREDICT+CLINICAL+SENSITIVITY+TO+THERAPIES&rft.inventor=LOOS%2C+Remco+Gerard&rft.inventor=POURDEHNAD%2C+Michael&rft.inventor=MACBETH%2C+Kyle+James&rft.inventor=FAN%2C+Jinhong&rft.inventor=PIERCE%2C+Daniel+Weston&rft.date=2022-09-07&rft.externalDBID=A1&rft.externalDocID=EP4051277A1